Literature DB >> 1700964

Immunohistochemical detection of keratins 1 and 13 as differentiation markers in the hormone-dependent human vaginal epithelium.

G Schaller1, T Genz.   

Abstract

Human vaginal epithelium provides a good model to study hormonally regulated differentiation. Differentiation in this tissue can be characterized by the expression of the keratins 1 and 13 which represent the epidermal and nonkeratinizing pathway in stratified epithelia, respectively. In the present study immunohistochemistry was applied on sections of vaginal epithelium derived from women at various stages of the menstrual cycle or during pregnancy. Our results demonstrate that both pathways are realized simultaneously during sexual maturity and that the maximum for synthesis of keratins 1 and 13 is seen during the first half of the cycle. In contrast keratin 1 is not detectable at the end of pregnancy, thus reflecting a completely suppressed epidermal differentiation. As the levels of the female sex hormones, i.e. estrogens, is significantly increased in pregnant women over that in nonpregnant women, these results suggest a possible role of estrogens in downregulating the epidermal differentiation pathway.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700964     DOI: 10.1159/000293225

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  2 in total

1.  Update of the keratin gene family: evolution, tissue-specific expression patterns, and relevance to clinical disorders.

Authors:  Minh Ho; Brian Thompson; Jeffrey Nicholas Fisk; Daniel W Nebert; Elspeth A Bruford; Vasilis Vasiliou; Christopher G Bunick
Journal:  Hum Genomics       Date:  2022-01-06       Impact factor: 6.481

Review 2.  The Effect of Gender-Affirming Medical Care on the Vaginal and Neovaginal Microbiomes of Transgender and Gender-Diverse People.

Authors:  Yonah Krakowsky; Emery Potter; Jason Hallarn; Bern Monari; Hannah Wilcox; Greta Bauer; Jacques Ravel; Jessica L Prodger
Journal:  Front Cell Infect Microbiol       Date:  2022-01-21       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.